Influence of plasma fibrinogen levels on the incidence of myocardial infarction and death is modified by other inflammation-sensitive proteins a long-term cohort study

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 21, Issue 3, 2001, Pages 452-458

  Lind, Peter ^a,b   Hedblad, B ^a   Stavenow, L ^a   Janzon, L ^a   Eriksson, K F ^a   Lindgarde F ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Atherosclerosis; Fibrinogen; Inflammation; Myocardial infarction; Plasma proteins

Indexed keywords

ALPHA 1 ANTITRYPSIN; CERULOPLASMIN; FIBRINOGEN; HAPTOGLOBIN; OROSOMUCOID; PLASMA PROTEIN;

ADULT; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; DEATH; FIBRINOGEN BLOOD LEVEL; HEART INFARCTION; HUMAN; INCIDENCE; INFLAMMATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL;

EID: 0035092681     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.21.3.452     Document Type: Article

References (41)

1. Fibrinogen as a risk factor for stroke and myocardial infarction
2. Fibrinogen as a cardiovascular risk factor: A metaanalysis and review of the literature
3. Fibrinogen as a risk factor for coronary heart disease and mortality in middle-aged men and woman: The Scottish Heart Health Study
4. Insoluble "fibrin" in human aortic intima: Quantitative studies on the relationship between insoluble "fibrin," soluble fibrinogen and low density lipoprotein
5. Fibrinogen, fibrin and fibrin degradation products in relation to atherosclerosis
6. Blood rheology, haemostasis and vascular disease
7. Acute-phase proteins and other systemic responses to inflammation
8. The pathogenesis of atherosclerosis: A perspective for the 1990s
9. Atherosclerosis: An inflammatory disease
10. Immunological mechanisms in atherosclerosis
11. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
12. Community-based preventive medical department for individual risk factor assessment and intervention in an urban population
13. Cardiovascular risk groups and mortality in an urban Swedish population: The Malmö Preventive Project
14. 1986 Guidelines for the treatment of mild hypertension: Memorandum from a WHO/ISH meeting
15. Electroimmuno assay
16. Intra-urban variations in incidence and mortality in myocardial infarction: A study from the myocardial infarction register in the city of Malmo, Sweden
17. Nonparametric estimation from incomplete observations
18. How to evaluate interaction between causes: A review of practices in cardiovascular epidemiology
19. Regression models and life tables
20. Pathology of arterial thrombosis
21. Increased secretion of tumor necrosis factor-α and interferon-γ by mononuclear leukocytes in patients with ischemic heart disease: Relevance in superoxide anion generation
22. Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall
23. Susceptibility to low density lipoprotein oxidation and coronary atherosclerosis in man
24. Does atherosclerosis have an infectious etiology?
25. Chronic infections and coronary heart disease: Is there a link?
26. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study
27. The phenomenon of the acute phase response
28. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein
29. The acute phase response is mediated by heterogeneous mechanisms
30. C-reactive protein immunohistochemical localization in normal and atherosclerotic human aortas
31. Long-term outcome of the Malmö Preventive Project: Mortality and cardiovascular morbidity
32. Self-rated health and mortality: A review of twenty-seven community studies
33. Stroke registry in Malmö, Sweden
34. Genetic and cultural inheritance of plasma fibrinogen concentration